Reasonable Attempt at a Randomized Trial in Relapsed Rhabdomyosarcoma

J Clin Oncol. 2021 Sep 20;39(27):2977-2978. doi: 10.1200/JCO.21.01631. Epub 2021 Aug 12.

Author

Affiliation

¹ Division of Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.

PMID: 34383578
DOI: 10.1200/JCO.21.01631

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Humans
Neoplasm Recurrence, Local* / drug therapy
Rhabdomyosarcoma* / drug therapy